Blood components

This tender for blood components is generally well-structured with clear basic information and EU funding. However, it lacks specific details on evaluation criteria and financial value, impacting completeness and fairness.

The tender adheres to EU procurement directives (Code: 2014/24/ES) and uses a standard open procedure. The CPV code is appropriate. No disputes are reported. The deadline, while potentially short, is within typical parameters for this type of procurement. The primary concern is the lack of specified evaluation criteria, which is a key component of legal compliance in public tenders.

The title and description are concise. The presence of a contract notice and tender structure document indicates a clear intent to provide necessary information. However, the absence of specific requirements for exclusion, eligibility, technical, financial, and submission aspects leaves significant room for interpretation.

Basic information such as title, reference, organization, and deadline is present. The contract duration is specified. However, the estimated value is not disclosed, and crucial details regarding the specific requirements for bidders are missing, which significantly impacts the completeness of the tender documentation.

The tender is open and EU-funded, suggesting a degree of fairness. The use of e-procurement is a positive aspect. However, the undisclosed estimated value and the lack of specified objective evaluation criteria could potentially lead to an uneven playing field or perceptions of bias. The absence of tailored requirements for specific companies is positive.

The tender is marked as 'E-Procurement', implying electronic submission is possible. The contract duration is reasonable. However, the 'No e-submission' flag in the checks section contradicts the 'E-Procurement' characteristic, creating ambiguity. The contract start date is not specified, and financing information is absent.

Key fields like title, reference, organization, and deadline are populated. The dates provided (submission and opening) are logical. There are no reported disputes or suspensions. The 'active' status is consistent with the submission deadline.

The tender is EU funded, which often implies adherence to certain standards. However, there are no explicit mentions of green procurement, social aspects, or innovation within the provided information. This suggests a lack of focus on these sustainability dimensions.